MACROBID Drug Patent Profile
✉ Email this page to a colleague
When do Macrobid patents expire, and what generic alternatives are available?
Macrobid is a drug marketed by Almatica and is included in one NDA.
The generic ingredient in MACROBID is nitrofurantoin; nitrofurantoin, macrocrystalline. There are twenty drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the nitrofurantoin; nitrofurantoin, macrocrystalline profile page.
Summary for MACROBID
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 11 |
| Raw Ingredient (Bulk) Api Vendors: | 85 |
| Clinical Trials: | 13 |
| Patent Applications: | 6,113 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for MACROBID |
| What excipients (inactive ingredients) are in MACROBID? | MACROBID excipients list |
| DailyMed Link: | MACROBID at DailyMed |
Recent Clinical Trials for MACROBID
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Albert Einstein Healthcare Network | Phase 4 |
| Baylor Research Institute | Phase 4 |
| National Cancer Institute (NCI) | Phase 4 |
Pharmacology for MACROBID
| Drug Class | Nitrofuran Antibacterial |
Anatomical Therapeutic Chemical (ATC) Classes for MACROBID
US Patents and Regulatory Information for MACROBID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Almatica | MACROBID | nitrofurantoin; nitrofurantoin, macrocrystalline | CAPSULE;ORAL | 020064-001 | Dec 24, 1991 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for MACROBID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Almatica | MACROBID | nitrofurantoin; nitrofurantoin, macrocrystalline | CAPSULE;ORAL | 020064-001 | Dec 24, 1991 | ⤷ Try a Trial | ⤷ Try a Trial |
| Almatica | MACROBID | nitrofurantoin; nitrofurantoin, macrocrystalline | CAPSULE;ORAL | 020064-001 | Dec 24, 1991 | ⤷ Try a Trial | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for MACROBID
See the table below for patents covering MACROBID around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Austria | A151587 | ⤷ Try a Trial | |
| New Zealand | 220695 | SUSTAINED RELEASE/RAPID RELEASE (COMBINED) PHARMACEUTICAL CAPSULES CONTAINING NITROFURANTOIN | ⤷ Try a Trial |
| Ireland | 871585 | ⤷ Try a Trial | |
| New Zealand | 220696 | SUSTAINED RELEASE PHARMACEUTICAL CAPSULES CONTAINING PARTICULATE MIXTURE OF POLYVINYLPYRROLIDONE AND CARBOXYVINYL POLYMER | ⤷ Try a Trial |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
